Anchor Investment Management LLC Has $75,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Anchor Investment Management LLC lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,398 shares of the pharmacy operator’s stock after selling 1,471 shares during the quarter. Anchor Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $75,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in WBA. Iron Horse Wealth Management LLC raised its position in Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares during the last quarter. TD Private Client Wealth LLC lifted its position in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Continuum Advisory LLC boosted its holdings in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares during the last quarter. Finally, Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance in the third quarter valued at $30,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 6.8 %

Shares of WBA stock opened at $10.39 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $27.05. The company has a market capitalization of $8.98 billion, a PE ratio of -1.04, a price-to-earnings-growth ratio of 1.36 and a beta of 0.66. The firm has a 50 day moving average price of $9.27 and a two-hundred day moving average price of $10.72. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the previous year, the company posted $0.67 EPS. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 9.62%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on WBA. Evercore ISI boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Jefferies Financial Group reduced their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Finally, Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.